Pre-market Hot Trades in US Stocks
Micron Technology is up 3.42% in pre-market trading. Based on recent important news:
<ol>
<li>
On September 10, Citigroup analysts pointed out that the demand for memory in the AI sector has surged, predicting that DRAM and NAND flash will be in short supply by 2026, driving up memory prices. Citigroup reiterated its &#34;Buy&#34; rating on Micron Technology.
</li>
<li>
On September 9, Stifel released a report stating that the market has underestimated Micron Technology's importance in the AI revolution, believing its technology is on par with or even superior to its peers.
</li>
<li>
On September 8, TrendForce's survey showed a significant increase in enterprise-level SSD demand, despite a shortage of DDR4, with market competition focusing on AI-driven technology iterations. Micron's revenue decreased by 7.9% in the second quarter. The memory market is experiencing tight supply and demand, with upward price pressure.
</li>
</ol>
Top Gainers in Pre-market Trading of US Stocks
Silexion Therapeutics is up 165.33% in pre-market trading, based on recent key news:
<ol>
<li>
On September 11, Silexion Therapeutics announced that its experimental therapy SIL20 successfully reached major metastatic sites, including the liver, peritoneum, and lungs, in preclinical studies, showing significant tumor burden reduction. This news drove the stock price sharply higher.
</li>
<li>
On September 11, the company stated it plans to begin further trials in the first half of 2026 and intends to submit regulatory applications in the fourth quarter of 2025 and the first quarter of 2026. This progress has boosted market confidence.
</li>
<li>
On September 11, Silexion Therapeutics reported that its SIL204 successfully reached all major pancreatic cancer metastatic sites after systemic administration, further solidifying its stock price uptrend. The biotechnology sector has recently performed strongly, with noticeable capital inflows.
</li>
</ol>
Vince Holding is up 140.36% in pre-market trading, based on recent key news:
<ol>
<li>
On September 10, Vince Holding reported a net income of $12.06 million for the second quarter, driving the stock price significantly higher. Data indicated earnings per share reached $0.93, far exceeding market expectations, stimulating investor confidence. Source: Reuters
</li>
<li>
On September 10, Vince Holding's management forecasted that net sales for the third quarter would remain flat or grow by 3%, and plans to mitigate tariff impacts through strategic measures. This optimistic outlook further propelled the stock price upward. Source: Company announcement
</li>
<li>
On September 10, Wall Street analysts rated Vince Holding as &#34;Buy,&#34; setting a 12-month target price of $3.25, indicating significant upside potential compared to the current stock price. Source: LSEG Data The luxury apparel sector has recently performed strongly
</li>
</ol>

Micron Tech pre-market up 3.42%; Silexion Therapeutics pre-market up 165.33%; Vince Holdings pre-market up 140.36%; Treasure Gbl pre-market up 93.95%

- Micron Technology's stock rose 3.42% in pre-market trading due to increased demand for memory in AI, with Citigroup reaffirming a "buy" rating.  
- Silexion Therapeutics surged 165.33% after announcing successful preclinical results for its SIL20 therapy, with plans for further trials in 2026.  
- Vince Holdings saw a 140.36% increase following a strong Q2 report, with earnings exceeding expectations and positive sales forecasts for Q3.

Pre-market hot trades in US stocks: Micron Tech up 3.42% in pre-market trading